Subscribe to RSS
DOI: 10.1055/a-1961-7186
Individuelle Behandlung bei Glaukompatienten mit einem Diabetes mellitus
Article in several languages: English | deutsch
Zusammenfassung
Das Glaukom und der Diabetes mellitus sind 2 in Europa und weltweit häufig vorkommende chronische Erkrankungen, die einer intensiven Therapie bedürfen. Pathophysiologisch werden verschiedene Mechanismen diskutiert, die vor allem beim Vorliegen eines Diabetes mellitus die Entstehung eines Glaukoms begünstigen. Die medikamentöse und chirurgische Einstellung des Augeninnendruckes ist bei Patienten mit einem Diabetes mellitus mit einigen Einschränkungen verbunden, so zeigen die filtrierenden Eingriffe geringere Erfolgsraten als bei nicht an Diabetes erkrankten Glaukompatienten. Neben der rein augenheilkundlich-endokrinologischen Therapie sollte ebenfalls die psychologische Belastung durch 2 chronische Erkrankungen bedacht und in den individuellen Therapieplan aufgenommen werden.
Publication History
Received: 17 August 2022
Accepted: 06 October 2022
Article published online:
12 January 2023
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References/Literatur
- 1
Tham YC,
Li X,
Wong TY.
et al.
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040. Ophthalmology
2014; 121: 2081-2090
MissingFormLabel
- 2
Bourne RRA,
Taylor HR,
Flaxman SR.
et al.
Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions
1990–2010: A Meta-Analysis. PLoS One 2016; 11: e0162229
MissingFormLabel
- 3
Jonas JB,
Aung T,
Bourne RR.
et al.
Glaucoma. Lancet 2017; 390: 2183-2193
MissingFormLabel
- 4
International Diabetes Federation.
ed.
IDF Diabetes Atlas, Tenth Edition. Diabetes around the World in 2021. Accessed August
13, 2022 at: https://diabetesatlas.org/atlas/tenth-edition/
MissingFormLabel
- 5
American Diabetes Association.
Standards of Medical Care in Diabetes–2019 Abridged for Primary Care Providers. Clin
Diabetes 2019; 37: 11-34
MissingFormLabel
- 6
Teo ZL,
Tham YC,
Yu M.
et al.
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic
Review and Meta-analysis. Ophthalmology 2021; 128: 1580-1591
MissingFormLabel
- 7
Virtanen A,
Haukka J,
Loukovaara S.
et al.
Diabetes mellitus and risk of open-angle glaucoma–A population-based follow-up study.
Acta Ophthalmol 2022;
MissingFormLabel
- 8
Deutsche Diabetes Gesellschaft (DDG),
diabetesDE – Deutsche Diabetes-Hilfe.
Hrsg.
Deutscher Gesundheitsbericht Diabetes 2022. Accessed September 27, 2022 at: https://www.diabetesde.org/system/files/documents/gesundheitsbericht_2022.pdf
MissingFormLabel
- 9
Li Y,
Mitchell W,
Elze T.
et al.
Association Between Diabetes, Diabetic Retinopathy, and Glaucoma. Curr Diab Rep 2021;
21: 38
MissingFormLabel
- 10
Hou H,
Moghimi S,
Baxter SL.
et al.
Is Diabetes Mellitus a Blessing in Disguise for Primary Open-angle Glaucoma?. J Glaucoma
2021; 30: 1-4
MissingFormLabel
- 11
Wang X,
Xu G,
Wang W.
et al.
Changes in corneal biomechanics in patients with diabetes mellitus: a systematic review
and meta-analysis. Acta Diabetol 2020; 57: 973-981
MissingFormLabel
- 12
Khawaja AP,
Crabb DP,
Jansonius NM.
The role of ocular perfusion pressure in glaucoma cannot be studied with multivariable
regression analysis applied to surrogates. Invest Ophthalmol Vis Sci 2013; 54: 4619-4620
MissingFormLabel
- 13
Tielsch JM,
Katz J,
Sommer A.
et al.
Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based
assessment. Arch Ophthalmol 1995; 113: 216-221
MissingFormLabel
- 14
Charlson ME,
de Moraes CG,
Link A.
et al.
Nocturnal systemic hypotension increases the risk of glaucoma progression. Ophthalmology
2014; 121: 2004-2012
MissingFormLabel
- 15
Su DHW,
Wong TY,
Wong WL.
et al.
Diabetes, hyperglycemia, and central corneal thickness: the Singapore Malay Eye Study.
Ophthalmology 2008; 115: 964-968.e1
MissingFormLabel
- 16
Shami SK,
Chittenden SJ.
Microangiopathy in diabetes mellitus: II. Features, complications and investigation.
Diabetes Res 1991; 17: 157-168
MissingFormLabel
- 17
Bonaventure N,
Roussel G,
Wioland N.
[Stereospecificity of the action of alpha-aminoadipic acid on the retina: a morphological
and electrophysiological study]. C R Seances Acad Sci III 1983; 296: 457-462
MissingFormLabel
- 18
Yanagi M,
Kawasaki R,
Wang JJ.
et al.
Vascular risk factors in glaucoma: a review. Clin Exp Ophthalmol 2011; 39: 252-258
MissingFormLabel
- 19
Sato T,
Roy S.
Effect of high glucose on fibronectin expression and cell proliferation in trabecular
meshwork cells. Invest Ophthalmol Vis Sci 2002; 43: 170-175
MissingFormLabel
- 20
Rodrigues GB,
Abe RY,
Zangalli C.
et al.
Neovascular glaucoma: a review. Int J Retina Vitreous 2016; 2: 26
MissingFormLabel
- 21
Havens SJ,
Gulati V.
Neovascular Glaucoma. Dev Ophthalmol 2016; 55: 196-204
MissingFormLabel
- 22
Zhou M,
Wang W,
Huang W.
et al.
Diabetes mellitus as a risk factor for open-angle glaucoma: a systematic review and
meta-analysis. PLoS One 2014; 9: e102972
MissingFormLabel
- 23
Zhao YX,
Chen XW.
Diabetes and risk of glaucoma: systematic review and a Meta-analysis of prospective
cohort studies. Int J Ophthalmol 2017; 10: 1430-1435
MissingFormLabel
- 24
Kjærsgaard M,
Grauslund J,
Vestergaard AH.
et al.
Relationship between Diabetic Retinopathy and Primary Open-Angle Glaucoma: A Systematic
Review and Meta-Analysis. Ophthalmic Res 2022; 65: 377-386
MissingFormLabel
- 25
Hou H,
Shoji T,
Zangwill LM.
et al.
Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients. Am
J Ophthalmol 2018; 189: 1-9
MissingFormLabel
- 26
European Glaucoma Society (EGS).
European Glaucoma Society Guidelines – 5th ed. 2021. Accessed October 22, 2022 at:
https://www.eugs.org/eng/guidelines.asp
MissingFormLabel
- 27
Przezak A,
Bielka W,
Pawlik A.
Hypertension and Type 2 Diabetes–The Novel Treatment Possibilities. Int J Mol Sci
2022; 23: 6500
MissingFormLabel
- 28
Siklos P,
Henderson RG.
Severe acidosis from acetazolamide in a diabetic patient. Curr Med Res Opin 1979;
6: 284-286
MissingFormLabel
- 29
Feldman-Billard S,
Du Pasquier-Fediaevsky L,
Héron E.
Hyperglycemia after repeated periocular dexamethasone injections in patients with
diabetes. Ophthalmology 2006; 113: 1720-1723
MissingFormLabel
- 30
Zhang YP,
Peng XY,
Li ZH.
et al.
Hyperglycemic effects of a periocular dexamethasone injection in diabetic patients
after vitreoretinal surgery. Biomed Environ Sci 2012; 25: 311-316
MissingFormLabel
- 31
Lin HC,
Stein JD,
Nan B.
et al.
Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma
in Persons With Diabetes Mellitus. JAMA Ophthalmol 2015; 133: 915-923
MissingFormLabel
- 32
Kim YS,
Kim M,
Choi MY.
et al.
Metformin protects against retinal cell death in diabetic mice. Biochem Biophys Res
Commun 2017; 492: 397-403
MissingFormLabel
- 33
Zhang X,
Hou A,
Cao J.
et al.
Association of Diabetes Mellitus With Postoperative Complications and Mortality After
Non-Cardiac Surgery: A Meta-Analysis and Systematic Review. Front Endocrinol (Lausanne)
2022; 13: 841256
MissingFormLabel
- 34
Law SK,
Hosseini H,
Saidi E.
et al.
Long-term outcomes of primary trabeculectomy in diabetic patients with primary open
angle glaucoma. Br J Ophthalmol 2013; 97: 561-566
MissingFormLabel
- 35
Hugkulstone CE,
Smith LF,
Vernon SA.
Trabeculectomy in diabetic patients with glaucoma. Eye (Lond) 1993; 7: 502-506
MissingFormLabel
- 36
Schlenker MB,
Gulamhusein H,
Conrad-Hengerer I.
et al.
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent
Implantation versus Standalone Trabeculectomy. Ophthalmology 2017; 124: 1579-1588
MissingFormLabel
- 37
Denk PO,
Hoppe J,
Hoppe V.
et al.
Effect of growth factors on the activation of human Tenonʼs capsule fibroblasts. Curr
Eye Res 2003; 27: 35-44
MissingFormLabel
- 38
Browning AC,
Alibhai A,
McIntosh RS.
et al.
Effect of diabetes mellitus and hyperglycemia on the proliferation of human Tenonʼs
capsule fibroblasts: Implications for wound healing after glaucoma drainage surgery.
Wound Repair Regen 2005; 13: 295-302
MissingFormLabel
- 39
Saarni SI,
Härkänen T,
Sintonen H.
et al.
The impact of 29 chronic conditions on health-related quality of life: a general population
survey in Finland using 15D and EQ-5D. Qual Life Res 2006; 15: 1403-1414
MissingFormLabel
- 40
Ko Y,
Coons SJ.
Self-reported chronic conditions and EQ-5D index scores in the US adult population.
Curr Med Res Opin 2006; 22: 2065-2071
MissingFormLabel
- 41
Mills T,
Law SK,
Walt J.
et al.
Quality of life in glaucoma and three other chronic diseases: a systematic literature
review. Drugs Aging 2009; 26: 933-950
MissingFormLabel
- 42
Groff ML,
Choi B,
Lin T.
et al.
Anxiety, depression, and sleep-related outcomes of glaucoma patients: systematic review
and meta-analysis. Can J Ophthalmol 2022;
MissingFormLabel
- 43
Zheng Y,
Wu X,
Lin X.
et al.
The Prevalence of Depression and Depressive Symptoms among Eye Disease Patients: A
Systematic Review and Meta-analysis. Sci Rep 2017; 7: 46453
MissingFormLabel
- 44
Azmiardi A,
Murti B,
Febrinasari RP.
et al.
Low Social Support and Risk for Depression in People With Type 2 Diabetes Mellitus:
A Systematic Review and Meta-analysis. J Prev Med Public Health 2022; 55: 37-48
MissingFormLabel